Has Stephanie Freels, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,392 in general payments to Stephanie Freels, MD across 537 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephanie Freels, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephanie Freels, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephanie Freels, MD

Procedural Dermatology · Saint Joseph, MINPI 1952319303

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 537 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,520 and has fallen 74.9% since, to $633 in 2024.

$10,392in general payments, 2019–2025

Across 537 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$2K
AbbVie$2K
Sun Pharmaceutical Industries Inc.$1K
Dermavant Sciences, Inc.$779
Ortho Dermatologics, A Division Of Bausch Health US, LLC$733
Pfizer$545
plus $3K from 21 others

What the payments were for

Travel & lodging$160%
Food & beverage$10,33699%
Education$400%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	87	$2,101
AbbVie(2 entities)	108	$1,813
Sun Pharmaceutical Industries Inc.	64	$1,234
Dermavant Sciences, Inc.	32	$779
Ortho Dermatologics, A Division Of Bausch Health US, LLC	33	$733
Pfizer	34	$545
Johnson & Johnson	33	$516
Lilly USA, LLC	24	$369
Almirall LLC	30	$366
Galderma Laboratories, L.p.	8	$234
Incyte Corporation	16	$230
LEO Pharma Inc.	14	$229
UCB, Inc.	6	$179
E.r. Squibb & Sons, L.L.C.	7	$173
Amgen	3	$162
EPI Health, LLC	9	$151
Mayne Pharma Commercial LLC	7	$145
VYNE Pharmaceuticals Inc.	6	$144
Arcutis Biotherapeutics, Inc.	3	$63
Encore Dermatology Inc.	3	$48
Dermira, Inc.	2	$44
Medimetriks Pharmaceuticals, Inc.	2	$38
Sandoz	2	$29
Regeneron Healthcare Solutions, Inc.	1	$28
Sanofi	1	$17
Aclaris Therapeutics, Inc.	1	$13
Sebela Pharmaceuticals Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COSENTYX$363
VTAMA$297
DUOBRII$260
ALTRENO$125
SILIQ$125
Otezla$120

How this compares

Too few procedural dermatology providers in Michiganto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$73,979

Medicare patients

311

Services billed

688

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluorouracil	48	$2,776
Betamethasone Dipropionate	45	$1,707
Clobetasol Propionate	37	$1,565
Betamethasone Valerate	32	$954
Mometasone Furoate	39	$769
Ketoconazole	33	$745
Imiquimod	16	$511
Fluocinonide	16	$451
Spironolactone	20	$250
Mupirocin	29	$205
Minocycline Hcl	19	$200
Prednisone	17	$29

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Saint Joseph

Iltefat HamzaviCanton$458K
Justin MaroneOwosso$6K
Yuelin XuLansing$6K
Lorna ThomasFarmington Hills$2K
Lori HaddadBirmingham$555
Joan Griner LichtTraverse City$326
Raymond DeanTraverse City$168
Helene DombrowskiDearborn$85
Michael FrankSterling Hts$72

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →